NKTR
Nektar Therapeutics
43.60$
-7.3%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 51.5% | 30.5% | 39.4% | 41.5% | 18.4% | 27.3% | 4.1% | 1.9% | 1.7% | 0.0% | 1.4% | – | – | |
| 48.5% | 69.5% | 60.6% | 58.5% | 81.6% | 72.7% | 100.0% | 100.0% | 98.3% | 100.0% | 98.6% | 100.0% | 99.4% | |
| 99.7% | 125.4% | 126.7% | 126.5% | 145.2% | 98.5% | 291.4% | 267.4% | 231.1% | 136.2% | 328.5% | 386.2% | 241.4% | |
| 87.6% | 72.5% | 93.1% | 87.3% | 78.6% | 58.7% | 232.8% | 152.8% | 134.6% | 52.2% | 123.7% | 126.0% | 97.9% | |
| 234.3% | 209.8% | 224.3% | 270.4% | 224.0% | 23.5% | 525.8% | 424.2% | 365.8% | 187.5% | 450.9% | 517.9% | 339.7% | |
| -185.8% | -140.3% | -163.7% | -211.9% | -142.4% | 49.2% | -425.8% | -324.2% | -267.4% | -87.5% | -352.3% | -417.9% | -240.4% | |
| 24.5% | 28.8% | 25.6% | 27.3% | 25.0% | 34.8% | 47.6% | 48.3% | 51.3% | 44.8% | 73.1% | 71.1% | 56.7% | |
| -190.1% | -176.3% | -170.2% | -222.7% | -153.6% | 24.0% | -485.9% | -373.9% | -301.6% | -165.3% | -412.9% | -397.8% | -287.1% | |
| -0.3% | -0.1% | -0.2% | 0.2% | 0.0% | -0.9% | 0.5% | -1.7% | -0.3% | 0.1% | 0.6% | 0.0% | 0.1% | |
| -189.8% | -176.2% | -170.1% | -222.9% | -153.6% | 24.9% | -486.4% | -372.2% | -301.3% | -165.4% | -413.4% | -401.0% | -287.8% | |
| -158.6% | -140.6% | -137.2% | -189.2% | -124.5% | 59.9% | -391.7% | -302.3% | -248.6% | -119.6% | -338.3% | -416.9% | -246.2% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.